Related Business Topics
Latest Headlines
Forbes.com - Nov. 9, 2009, 10:13 AM
BANGALORE, Nov 9 (Reuters) - Shares of Compugen Ltd rose as much as 21 percent after the company said it discovered a genetic variation that could predict type 2 diabetes, a potentially valuable indicator in a multi-billion dollar market. Compugen From ...
Forbes.com - Oct. 27, 2009, 4:57 AM
Oct 27 (Reuters) - Compugen Ltd: * Reports third quarter 2009 financial results * Q3 loss per share ...
Forbes.com - Oct. 26, 2009, 4:49 AM
BusinessWire - --Platform Published in Proceedings of the National Academy of Sciences Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. (NASDAQ:CGEN) project manager Dr. Yossef Kliger provided an overview of Compugen's ...
Forbes.com - Oct. 20, 2009, 5:45 AM
BusinessWire - Compugen Ltd. (NASDAQ:CGEN) today announced that the Company plans to host a live conference call and webcast at 10:00 AM EDT on Tuesday, October 27, 2009 to review third quarter 2009 results. The quarterly results will be released prior ...
Forbes.com - Oct. 13, 2009, 7:05 AM
(The following was issued by Israel's Compugen ): Oct 13 - Compugen Ltd. Following an initial six month joint research stage, the agreement provides Bayer with an option for an exclusive worldwide royalty bearing license for development of monoclonal ...
Forbes.com - Oct. 13, 2009, 6:05 AM
Oct 13 (Reuters) - Compugen Ltd: * Compugen oncology target and splice variants ((Bangalore Equities Newsroom; +91 80 4135 5800; within ...
CNBC - Oct. 13, 2009, 5:52 AM
(The following was issued by Israel's Compugen ): Oct 13 - Compugen Ltd. (NASDAQ:CGEN) announced today that they have signed a collaboration agreement with Bayer Schering Pharma AG, Germany ('Bayer') covering the further evaluation of a Compugen ...
Reuters - Oct. 13, 2009, 5:36 AM
(The following was issued by Israel's Compugen (CGEN.O: Quote, Profile, Research) (CGEN.TA: Quote, Profile, Research)): Oct 13 - Compugen Ltd. (NASDAQ:CGEN) announced today that they have signed a collaboration agreement with Bayer Schering Pharma AG, ...
Forbes.com - Oct. 13, 2009, 5:12 AM
BusinessWire - --Existence of targets was predicted in silico using Compugen's Monoclonal Antibody Targets Discovery Platform Compugen Ltd. (NASDAQ:CGEN) announced today that they have signed a collaboration agreement with Bayer Schering Pharma AG, ...
CNBC - Oct. 13, 2009, 4:52 AM
(BUSINESS WIRE) -- --Existence of targets was predicted in silico using Compugen's Monoclonal Antibody Targets Discovery Platform Compugen Ltd. (NASDAQ:CGEN) announced today that they have signed a collaboration agreement with Bayer Schering Pharma AG, ...
